Suggestions
Daniel Brami
Associate Director, ITBP, NGS Data & Technologies at Bristol-Myers Squibb
Professional Background
Daniel Brami, MBA, is a distinguished professional in the biotechnology sector, combining a robust technical background with profound business insights. His extensive career spans over a decade, during which he has excelled in various prominent roles at Fortune 500 companies as well as innovative start-ups. Daniel is particularly passionate about enhancing healthcare outcomes through the application of informatics and machine learning, areas in which he has accumulated significant expertise.
Daniel’s career trajectory has seen him serve in critical positions that involve the commercialization of complex products at various stages of the product life cycle. His roles have included significant responsibilities such as managing global software partnerships and leading bioinformatics services at Illumina, one of the leading companies in genomics. He is recognized for his ability to intertwine creative thinking with data-driven decision-making, a powerful blend that allows him to effectively tackle challenges in the ever-evolving health tech landscape.
Education and Achievements
Daniel's academic background is as diverse as his professional experiences. He holds a Master of Business Administration from the University of California, San Diego, where he honed his business acumen and learned to lead in complex environments. His undergraduate education includes a Bachelor of Science in Bioinformatics from Université De Montréal, coupled with a Bachelor of Science in Biology from Concordia University. This combination of degrees equips Daniel with a unique understanding of both the scientific and commercial demands of the biotechnology field.
In addition to his formal education, Daniel has continuously sought opportunities to expand his knowledge. He has undertaken various studies at prestigious institutions, including the Rady School of Management at UC San Diego, further enhancing his qualifications.
Achievements
Throughout his career, Daniel has held pivotal roles that affirm his capabilities and contributions to the field of biotechnology. As a former IT Business Partner focused on Genomics and NGS Data at Bristol-Myers Squibb, he played a crucial role in integrating advanced computational solutions into the genomics domain, ensuring that the company remained at the forefront of technological advancements.
At Illumina, Daniel’s array of roles, from Portfolio Manager to Global Software Partnership Manager, showcase his versatile skill set and ability to drive product innovation. His leadership as the Bioinformatics Services Product Manager enabled him to steer projects that significantly enhanced the company’s service offerings in response to market needs.
Daniel also brings experience from his time at Synthetic Genomics, where he excelled as a Product Owner and Senior Research Associate in Bioinformatics and Software Engineering. His foundational experience began at the J. Craig Venter Institute, a renowned hub for genomic research, where he further developed his technical proficiency as a Bioinformatics Engineer.
His earlier roles, including working in quality control and production management at Laboratoires Delon, reflect his thorough understanding of the operational aspects of biotechnology enterprises, enabling him to appreciate both the technical and business dimensions of the industry.
Outside of his role in corporate settings, Daniel has actively participated in the broader field of bioinformatics through memberships in professional organizations such as Scrum Alliance, where he engages with peers to drive innovations in management practices within the tech community.
In summary, Daniel Brami is a dedicated and skilled biotechnology professional whose diverse experiences and comprehensive education empower him to make significant contributions to healthcare advancements. His passion for informatics and machine learning, combined with his proven business acumen, positions him as a leader in commercializing biotechnology innovations effectively.
